CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory ...

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency ...

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 ...

In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of ...

MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.

In July 2015, Abbott agreed to buy Tendyne for $225 million upfront and secured an option to acquire Cephea. Abbott CEO ...

The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...